PATENT CLAIM ANALYSIS

Application Number: 15873762
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "282000"]

Abstract:
Methods are provided for attenuating or preventing μ-opioid receptor mediated tolerance and opioid-induced hyperalgesia in a subject in need of acute or chronic opioid treatment for pain or in need of opioid anesthesia.

Claim (Index 5):
The method of  claim 1 , wherein the composition is selected in contemplation of the respective pharmacokinetic properties of the antagonist and the agonist so that effective blood concentrations of the antagonist and agonist exist from treatment start on.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10319789', '13560620', '13189954', '14246847', '13076386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8043973605870819
- 35 USC 102 Novelty (BERT): 0.5467972446491292
- Combined Prediction Score: 0.7786373489932866
- Mean Citation Score: 344.695056
- Max Citation Score: 414.39047
- Similarity Product: 284.6276063650435

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test